Frantz EyeCare reports 98% of Light Adjustable Lens patients achieved refractive accuracy within ±0.50 D of target, exceeding published national cataract surgery benchmarks.
|Articles|November 15, 2020
- Ophthalmology Times: November 15, 2020
- Volume 45
- Issue 19
Dreaming in a blur
Author(s)Jon Carter
Check out the latest cartoon!
Advertisement
Articles in this issue
almost 6 years ago
Evaluating scleral biomechanics to pinpoint root of accommodationalmost 6 years ago
FA implant outperforms anti-VEGF in DR patients lost to follow-upalmost 6 years ago
Challenges to topical drop adherence after cataract surgeryalmost 6 years ago
Gene therapy surgical pearls for successful outcomesalmost 6 years ago
Eliminating preop fasting leads to happier cataract patientsalmost 6 years ago
Pearls for drawing patients back to your practicealmost 6 years ago
Haptic flanging reduces IOL dislocations after cataract surgeryalmost 6 years ago
AMA steps up support for gender equity in medicinealmost 6 years ago
Ophthalmic practices eye private equity investorsalmost 6 years ago
Oh, the people we meetAdvertisement
Related to this article
In this Q&A, Ping Moore, OD, covers emerging dry eye therapies, from selenium sulfide to next-gen cyclosporine, and how subtype-guided care shapes treatment choices.
Ophthalmology is projected to face one of the steepest physician shortages of any subspecialty by 2038.
Two investigational pipeline therapies take aim at the root causes of dry eye disease
Dry eye care pivots to root-cause diagnosis and personalized biologics/devices,
Cataract surgery becomes refractive: learn how IOL choices and preop counseling across distance, intermediate and near turn 20/20 into 20/happy.
Findings from the third annual State of Dry Eye survey link symptom management to quality of life gains, including lower anxiety and improved self-confidence.
June brings FDA clearance for Lumvoa, key retina and glaucoma trials, device deals, and hard truths on AI performance in eye care.
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
FDA approves subcutaneous Enspryng for TED
2
OT Roundup: Optogenetics Nobel Prize, BRUNELLO, DRAGON, eye transplant
3
FDA approves phentolamine ophthalmic solution 0.75% (Ryzumvi) for presbyopia
4
AAO 2026: Vamikibart shows sustained gains in uveitic macular edema as FDA accepts BLA
5